Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2023 Filed Aug 22, 2023 22:13 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
Tax withholdingOrdinary Shares | 10,461 | $9.70 | $101,471.70 |
DisclosureSEC source: 0001415889-23-012514 · form4-08222023_100854.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,285 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 22:17 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 7,114 | $9.70 | $69,005.80 |
DisclosureSEC source: 0001415889-23-012520 · form4-08222023_100801.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,859 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 22:09 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,322 | $9.99 | $23,196.78 |
DisclosureSEC source: 0001415889-23-012271 · form4-08152023_100836.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 349,746 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 22:14 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,322 | $9.84 | $22,848.48 |
DisclosureSEC source: 0001415889-23-011244 · form4-07182023_100756.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,068 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:14 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,322 | $10.69 | $24,822.18 |
DisclosureSEC source: 0001415889-23-009963 · form4-06162023_100650.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,390 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 22:08 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
SaleOrdinary Shares | 1,790 | $11.13 | $19,922.70 |
DisclosureSEC source: 0001415889-23-009636 · form4-06122023_100608.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,833 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. Read SEC document |
| May 20, 2023 Filed May 23, 2023 23:44 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 11,469 | $11.21 | $128,567.49 |
DisclosureSEC source: 0001415889-23-008672 · form4-05232023_110508.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,209 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. F2 · balance_after: Includes 720 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2023. Read SEC document |
| May 20, 2023 Filed May 23, 2023 23:40 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
Tax withholdingOrdinary Shares | 5,567 | $11.21 | $62,406.07 |
DisclosureSEC source: 0001415889-23-008668 · form4-05232023_110503.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,623 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| May 20, 2023 Filed May 23, 2023 23:48 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 15,804 | $11.21 | $177,162.84 |
DisclosureSEC source: 0001415889-23-008676 · form4-05232023_110517.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,627,573 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| May 20, 2023 Filed May 23, 2023 23:46 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 8,744 | $11.21 | $98,020.24 |
DisclosureSEC source: 0001415889-23-008674 · form4-05232023_110519.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,973 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| May 20, 2023 Filed May 23, 2023 23:41 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
Tax withholdingOrdinary Shares | 10,460 | $11.21 | $117,256.60 |
DisclosureSEC source: 0001415889-23-008670 · form4-05232023_110546.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,712 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:17 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,322 | $11.26 | $26,145.72 |
DisclosureSEC source: 0001415889-23-008228 · form4-05172023_100533.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,172 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:48 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007384 · form4-05042023_100524.xml · derivative · entry 2 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:48 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007384 · form4-05042023_100524.xml · nonDerivative · entry 1 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,879 Read SEC document |
| May 02, 2023 Filed May 4, 2023 18:41 UTC |
MALKIEL BURTON GDirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007378 · form4-05042023_100556.xml · derivative · entry 3 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 18:41 UTC |
MALKIEL BURTON GDirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007378 · form4-05042023_100556.xml · nonDerivative · entry 1 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,589 Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:43 UTC |
MITCHELL DEAN JDirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007380 · form4-05042023_100558.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:43 UTC |
MITCHELL DEAN JDirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007380 · form4-05042023_100558.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,018 Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:36 UTC |
BROSHY ERANDirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007374 · form4-05042023_100502.xml · derivative · entry 2 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:36 UTC |
BROSHY ERANDirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007374 · form4-05042023_100502.xml · nonDerivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,018 Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:46 UTC |
O'Connor DonalDirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007382 · form4-05042023_100535.xml · derivative · entry 2 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:46 UTC |
O'Connor DonalDirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007382 · form4-05042023_100535.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,018 Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:38 UTC |
GRAY SUSANNAHDirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007376 · form4-05042023_100555.xml · derivative · entry 2 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:38 UTC |
GRAY SUSANNAHDirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007376 · form4-05042023_100555.xml · nonDerivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,951 Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:33 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 22,044 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001415889-23-007372 · form4-05042023_100550.xml · derivative · entry 2 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,044 Underlying: Ordinary Shares · 22,044 shares Expires 2033-05-01 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:33 UTC |
Smaldone Alsup LaurieDirector
|
GrantOrdinary Shares | 9,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007372 · form4-05042023_100550.xml · nonDerivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,794 Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:49 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,323 | $11.88 | $27,597.24 |
DisclosureSEC source: 0001415889-23-006620 · form4-04182023_090429.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,494 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 23:04 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,323 | $10.32 | $23,973.36 |
DisclosureSEC source: 0001415889-23-005044 · form4-03162023_110312.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,817 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:57 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
SaleOrdinary Shares | 4,000 | $10.20 | $40,800.00 |
DisclosureSEC source: 0001415889-23-004799 · form4-03132023_090313.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,190 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 00:34 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,323 | $10.05 | $23,346.15 |
DisclosureSEC source: 0001415889-23-004552 · form4-03092023_120346.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,140 F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:35 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
GrantOrdinary Shares | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004273 · form4-03042023_010337.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,958 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:29 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
GrantOrdinary Shares | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004269 · form4-03042023_010344.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,190 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:41 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GrantOrdinary Shares | 330,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004277 · form4-03042023_010303.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643,377 F1 · shares: On March 1, 2023, the reporting person was granted 330,000 RSUs. 165,000 RSUs are subject to service-based vesting conditions and the remaining 165,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:38 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
GrantOrdinary Shares | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004275 · form4-03042023_010338.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,717 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:32 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
GrantOrdinary Shares | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004271 · form4-03042023_010324.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,463 Read SEC document |
| February 26, 2023 Filed Mar 1, 2023 01:17 UTC |
GRAY SUSANNAHDirector
|
GrantShare Option (Right to Buy) · Derivative | 4,666 | $0.00 Strike: $9.87 | $0.00 |
DisclosureSEC source: 0001415889-23-003569 · form4-03012023_010311.xml · derivative · entry 4 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,666 Underlying: Ordinary Shares · 4,666 shares Expires 2033-02-25 F2 · derivative.exercise_date: This option shall vest monthly over two months of service from the date of grant and will vest in full upon earlier of the two-month anniversary of Susannah Gray's appointment to the Board or the date of Company's 2023 annual meeting of Shareholders. Read SEC document |
| February 26, 2023 Filed Mar 1, 2023 01:17 UTC |
GRAY SUSANNAHDirector
|
GrantShare Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $9.87 | $0.00 |
DisclosureSEC source: 0001415889-23-003569 · form4-03012023_010311.xml · derivative · entry 3 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Ordinary Shares · 28,000 shares Expires 2033-02-25 F1 · derivative.exercise_date: The option vests monthly over 24 months of service from the date of grant. Read SEC document |
| February 26, 2023 Filed Mar 1, 2023 01:17 UTC |
GRAY SUSANNAHDirector
|
GrantOrdinary Shares | 1,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003569 · form4-03012023_010311.xml · nonDerivative · entry 2 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,819 Read SEC document |
| February 26, 2023 Filed Mar 1, 2023 01:17 UTC |
GRAY SUSANNAHDirector
|
GrantOrdinary Shares | 10,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003569 · form4-03012023_010311.xml · nonDerivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,131 Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 00:23 UTC |
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 10,198 | $10.44 | $106,467.12 |
DisclosureSEC source: 0001415889-23-003071 · form4-02232023_120242.xml · nonDerivative · entry 1 Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,958 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 00:18 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
Tax withholdingOrdinary Shares | 7,119 | $10.44 | $74,322.36 |
DisclosureSEC source: 0001415889-23-003061 · form4-02232023_120227.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,190 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 00:29 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 37,420 | $10.44 | $390,664.80 |
DisclosureSEC source: 0001415889-23-003078 · form4-02232023_120232.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313,377 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 00:27 UTC |
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 6,783 | $10.44 | $70,814.52 |
DisclosureSEC source: 0001415889-23-003075 · form4-02232023_120258.xml · nonDerivative · entry 1 Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,717 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 00:21 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
Tax withholdingOrdinary Shares | 12,057 | $10.44 | $125,875.08 |
DisclosureSEC source: 0001415889-23-003065 · form4-02232023_120239.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,463 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| December 14, 2022 Filed Dec 17, 2022 00:36 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
SaleOrdinary Shares | 50,000 | $11.19 | $559,500.00 |
DisclosureSEC source: 0001415889-22-012648 · form4-12172022_121226.xml · nonDerivative · entry 2 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350,797 F2 · price: This transaction was executed in multiple trades at prices from $11.17 to $11.235 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2022 Filed Dec 17, 2022 00:36 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
GiftOrdinary Shares | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-012648 · form4-12172022_121226.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400,797 F1 · price: Bona Fide Gift. No compensation was given to the donor for the gifting of shares. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:59 UTC |
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
|
SaleOrdinary Shares | 2,084 | $10.73 | $22,361.32 |
DisclosureSEC source: 0001415889-22-012077 · form4-12052022_101216.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,520 Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 23:57 UTC |
O'Connor DonalDirector
|
Disposition to issuerOrdinary Shares | 10,000 | $10.50 | $105,000.00 |
DisclosureSEC source: 0001415889-22-011763 · form4-11232022_111144.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,886 F1 · shares: Represents ordinary shares tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's Dutch auction tender offer for up to $95 million of its ordinary shares. Read SEC document |
| November 20, 2022 Filed Nov 22, 2022 21:02 UTC |
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
|
Tax withholdingOrdinary Shares | 23,268 | $10.85 | $252,457.80 |
DisclosureSEC source: 0001415889-22-011667 · form4-11222022_091107.xml · nonDerivative · entry 1 Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,309 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| November 20, 2022 Filed Nov 22, 2022 21:09 UTC |
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingOrdinary Shares | 15,804 | $10.85 | $171,473.40 |
DisclosureSEC source: 0001415889-22-011673 · form4-11222022_091120.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409,797 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. F2 · balance_after: Includes 817 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.